Improving quality of life for 25k patients living with chronic conditions
![](/assets/projects/Wellkind/Wellkind.png)
My role
Product Design Lead
Deliverables
MVP workshop
Feature prioritization
Solution overview
Product design
Brand integration
Dev support
Sales prototype
Overview
VMS BioMarketing, the leading provider of patient engagement & adherence solutions, contracted with our Innovatemap team to deliver a best-in-class mobile app to improve a patients experience on this new journey in their lives.
Patient problems that drove my decision-making
-
Patients struggle to find and trust information about their drug
-
60% of patients delay start or abandon treatment, because drugs are expensive
-
Patient engagement calls are often for dosage and appointments, leaving less time for patients needing immediate care
-
Nursing staff is asked to do more with less, as product and patient counts grow
Our Hypothesis
If we can educate, teach, and create long-term relationships between a patient and their wellness journey, then more patients are likely to start treatment
Impact
Our work on Wellkind app was recognized as a 2022 Most Innovative Product by PM360 publication. Read about it!
Assortment of different product assets created during this project
What it means for VMW BioMarketing
-
VMS BioMarketing has begun onboarding 25k patients on to the product
-
reduced "simple" engagement call volume by ~5-10% freeing up more time for impactful calls with patients
Big thank you to the rest of the team
-
Spencer Abrams, PM
-
Parker McCullough, Brand
-
Kaylee Green, Brand
-
Yharlei Chamboneth, Motion
-
EIG, Engineering Firm
Additional process documents and deliverables
![](/assets/projects/wellkind/PriorityMatrix.png)
![](/assets/projects/wellkind/so.png)
![](/assets/projects/wellkind/Progressive.gif)
![](/assets/projects/wellkind/blockframes.png)
![](/assets/projects/wellkind/onboarding.gif)
![](/assets/projects/wellkind/confidence.png)
![](/assets/projects/wellkind/faq.png)
![](/assets/projects/wellkind/Notification.png)